Pulmonary gas exchange and sputum cellular responses to inhaled leukotriene D(4) in asthma. 2001

A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
Servei de Pneumologia i Al.lèrgia Respiratòria, Departament de Medicina, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Villaroel 170, 08036-Barcelona, Spain.

Inhalational challenges with inflammatory mediators may provoke lung function disturbances similar to those shown in spontaneous acute asthma. Cysteinyl leukotrienes (CysLTs) have recently been established as mediators of bronchoconstriction in asthma but their effects on pulmonary gas exchange in asthma have not been assessed. We therefore investigated the effects of leukotriene D(4) (LTD(4)) challenge resulting in a significant decrease in FEV(1) (mean +/- SE, by 32 +/- 3%) in 13 nonsmoking, mild asthmatics. Respiratory system resistance (Rrs), and respiratory and inert gases were measured before and immediately after, and at 15 and 45 min after challenge. After bronchoprovocation, Rrs increased (by 106 +/- 12%), Pa(O(2)) decreased (by 25 +/- 4 mm Hg), and ventilation-perfusion distributions moderately to severely deteriorated, as shown by increases in the dispersions of pulmonary blood flow (Log SDQ, by 59 +/- 12%) and alveolar ventilation (Log SDV, by 65 +/- 20%) (p < 0.05 each). Sputum eosinophils (p < 0.05) and urinary LTE(4) (p < 0.005) increased after challenge. Despite the lack of mathematical correlations between spirometric and Rrs changes and gas exchange indices, the pattern of improvement of the functional variables after challenge ran in parallel. These findings support the evidence that CysLTs, in addition to being potent bronchoconstrictors, also provoke profound disturbances of pulmonary gas exchange in asthma.

UI MeSH Term Description Entries
D008297 Male Males
D011659 Pulmonary Gas Exchange The exchange of OXYGEN and CARBON DIOXIDE between alveolar air and pulmonary capillary blood that occurs across the BLOOD-AIR BARRIER. Exchange, Pulmonary Gas,Gas Exchange, Pulmonary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced
D017998 Leukotriene D4 One of the biologically active principles of SRS-A. It is generated from LEUKOTRIENE C4 after partial hydrolysis of the peptide chain, i.e., cleavage of the gamma-glutamyl portion. Its biological actions include stimulation of vascular and nonvascular smooth muscle, and increases in vascular permeability. (From Dictionary of Prostaglandins and Related Compounds, 1990) LTD4,Leukotriene D,Leukotriene D-4,Leukotrienes D,Leukotriene D 4

Related Publications

A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
June 2008, The European respiratory journal,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
November 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
October 2001, American journal of respiratory and critical care medicine,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
April 2001, The European respiratory journal,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
April 1997, American journal of respiratory and critical care medicine,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
August 1994, American journal of respiratory and critical care medicine,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
October 2016, ERJ open research,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
October 2012, European journal of clinical pharmacology,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
June 2007, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
A L Echazarreta, and B Dahlén, and G García, and C Agustí, and J A Barberà, and J Roca, and S E Dahlén, and R Rodriguez-Roisin
December 1992, The American review of respiratory disease,
Copied contents to your clipboard!